6 best EDC platforms for HIPAA compliance in clinical trials in 2026

A sponsor security questionnaire asks whether your electronic data capture (EDC) platform is HIPAA certified, and you know no such certificate exists. What your quality assurance (QA) and information technology (IT) reviewers can file is a documented Health Insurance Portability and Accountability Act (HIPAA) security assessment, independent attestations, and an access model that survives inspection. Viedoc's EDC software supplies that evidence as standard, with a published HIPAA Security Standards Compliance Assessment, ISO 27001:2022 certification covering every Annex A control company-wide, a SOC 2 Type 2 report, and a 100% pass rate across every FDA inspection its studies have faced. This comparison reviews six EDC platforms across published security evidence, access control and user attribution, overlap with 21 CFR Part 11, and how protected health information (PHI) is hosted and shared.

You're not solving HIPAA in the abstract. You're deciding whether the platform your sites log into daily can demonstrate minimum-necessary access, record who saw which participant's data, and give your validation team documentation specific enough to close a computer system validation (CSV) package without a six-week email chain.

Enterprise suites answer that with a portal and a services engagement, which works if you have a dedicated CSV function and the budget to keep it busy. Commodity tools offer the controls but not the release documentation or attestation depth a regulated commercial trial needs. The platforms below are judged on what they publish and how much of your compliance burden they absorb rather than transfer.

Best EDC platforms for HIPAA compliance: quick comparison

The 6 best EDC platforms for HIPAA compliance reviewed

These six eClinical platforms are the options most often evaluated for HIPAA compliance, reviewed across published security evidence, access control and attribution, Part 11 overlap, and PHI hosting.

1. Viedoc

Viedoc's EDC software is unusually direct about HIPAA evidence, publishing a HIPAA Security Standards Compliance Assessment alongside a Data Protection Impact Assessment and the Technical and Organizational Measures attached to every Data Processing Agreement. Its information security management system is certified to ISO 27001:2022 with all Annex A controls in scope, and its SOC 2 Type 2 report is available on request. Across 8,000 studies in more than 75 countries, every Viedoc study that has faced FDA scrutiny has passed.

The access model matters as much as the certificates. Study-based licensing with unlimited user seats gives sites no reason to share a login, which is what preserves unique user attribution in the audit trail. For contract research organizations (CROs) scaling delivery, Viedoc also runs a tiered cro program with a certified partner network.

For validation teams, the Viedoc Inspection Readiness Packet (VIRP) is the practical differentiator. Every release ships with a Validation Summary Report, User Requirement Specification, traceability matrix, and release certificate your Organization Admin downloads directly, documentation you would otherwise write yourself.

Users notice the audit trail in daily work. "Viedoc is a user friendly EDC which provides seamless navigation. Report generation is easy. Outstanding customer support from the technical team. It really helps for Clinical data management activities and resolving queries. Audit trail generation in PDF format is a good feature." – Dr. Vijay K., Assistant General Manager.

Verified proof points:

• HIPAA evidence: Published HIPAA Security Standards Compliance Assessment and Technical and Organizational Measures
• Certifications: ISO 27001:2022 with all Annex A controls, SOC 2 Type 2 on request, CSA STAR Level One
• Inspection record: 100% FDA inspection pass rate; VIRP issued every release
• Access model: Unlimited user seats, no per-user fees, study-based licensing
• Scale: 8,000 studies, 140,000+ users, 30,000+ sites, 75+ countries, 40+ languages, 99.99% uptime on Microsoft Azure

2. Medidata

Medidata offers Rave, the EDC at the core of the Medidata Platform, which aggregates and reconciles data across adjacent applications including eConsent, eCOA, RTSM, imaging, and safety. Rave handles protocol amendments and mid-study changes without system downtime, supports single sign-on and on-demand site training, and brings electronic health record data into EDC through Rave Companion. A Rave Lite tier is positioned for Phase I, Phase IV, and medical device post-market studies.

On security documentation, Medidata publishes ISO 27001:2022, ISO 27017, ISO 27018, and ISO 27701 certifications, a SOC 2+ Type II report, penetration test results, vulnerability scan summaries, and a subprocessor list. Its regulatory compliance site holds documented position statements covering 21 CFR Part 11, EU GMP Annex 11, ICH E6 (R2) and (R3), Japan's MHLW, and China's NMPA. Some of that documentation requires an iMedidata account to access.

3. Veeva

Veeva offers Veeva EDC, part of Veeva Clinical Data alongside Veeva DQS and Veeva eCOA on the Vault Platform. The application covers case report form design and quality control checks at study start, then collects patient form data, local labs, and medical coding during execution, with querying, targeted source data verification, and protocol deviations handled in-product. At study close it provides data lock, automatic end-of-study media creation, and archiving.

Veeva is audited annually against ISO 27001, ISO 27017, and ISO 27018 controls, holds ISO 9001 certification, and publishes a SOC 2 Type II report under the Security and Availability Trust Service Principles. Data is encrypted at rest using AES-256 and in transit using TLS 1.2 or above, third-party penetration testing runs at least annually, and independent GxP audit reports can be purchased through Rx-360, USDM, and Diligent Pharma.

4. Castor EDC

Castor EDC is a cloud EDC and clinical data management system built around a low-code builder for electronic case report forms (eCRFs), sitting on one database with Castor eCOA, eConsent, and Catalyst so data moves without separate reconciliation. Castor states that low-complexity studies deploy in as little as 3–4 weeks, with platform uptime above 99.9%. Study data is stored on certified servers in supported regions, protected with field-level encryption and two-factor authentication, and amendments are validated in separate test environments before deployment.

For US teams, Castor publishes a combined assessment of its GDPR and HIPAA compliance, and it is ISO 27001 and ISO 9001 certified, validated for 21 CFR Part 11, and built to meet ICH E6(R3), EU Annex 11, and EU MDR 2017/745 requirements for post-market clinical follow-up. Castor was founded in Amsterdam in 2012 and serves sponsors, CROs, biotech, and device companies.

5. Medrio

Medrio provides Medrio CDMS/EDC, a no-code platform aimed at small and scaling clinical teams, with point-and-click study builds, a template library, and form copy functionality. An always-on validation environment lets teams test form rules and queries and deploy updates without data migration or system downtime, and the platform supports unplanned offline data capture, targeted monitoring workflows, and rolling database locks.

Medrio states that the platform includes validated electronic records and signatures, full audit trails, role-based access controls, and data encryption aligned with FDA 21 CFR Part 11, ICH E6(R2), HIPAA and HITECH, and GDPR, alongside ICH GCP, Annex 11, CDASH and CDISC, ISO 9001, ISO 27001, and SOC 2. Listed controls include two-factor authentication, single sign-on, session time-outs, user lock-out, daily full backups, and documented disaster recovery. The suite extends to ePRO, eConsent, RTSM, CTMS, and eTMF, with more than 20 years of clinical use behind it.

6. Oracle

Oracle offers Oracle Life Sciences Clinical One Data Collection, a cloud application that unifies clinical data capture from electronic health records, labs, and patient applications on a single platform built on Oracle Cloud Infrastructure. Oracle positions the product beyond conventional EDC, harmonizing datasets from multiple sources in one place for review and integration across every study in a program.

Recent releases added electronic health record interoperability through the Oracle Clinical Connector, integration with Oracle Safety One Argus, and site- and subject-level document management supporting all file formats alongside structured data. Clinical One Data Collection connects to Oracle Clinical One RTSM for randomization and supply management, and Oracle reports use by CROs including Atorus Research, Excelya, and FHI Clinical.

What to look for in EDC platforms for HIPAA compliance

Evidence you can actually put in a validation file

No accredited body certifies HIPAA compliance, so any vendor claiming to be HIPAA certified is telling you something that cannot be true. What your QA function can file is documentation: a written assessment against the HIPAA Security Rule safeguards, an independent attestation such as SOC 2 Type 2, a current ISO 27001 certificate with its statement of applicability, and evidence of penetration testing.

Best practice is a vendor that publishes this without an account or a sales call. Viedoc's security and compliance documentation includes a HIPAA Security Standards Compliance Assessment and a Validation Summary Report issued with every release inside VIRP.

Treat a vendor that answers with a badge rather than a document as future work for your own team.

An access model that preserves unique user attribution

Both the HIPAA Security Rule and 21 CFR Part 11 depend on knowing which individual did what. That breaks the moment a coordinator shares a login, and per-seat licensing quietly encourages exactly that at sites running several studies on tight budgets.

Look at how the platform charges for users before you look at its access control matrix. Unlimited-seat, study-based licensing removes the incentive to share credentials, and role-based permissions then let you apply minimum necessary access to identifiable fields rather than granting whole-study visibility by default.

Overlap between the Security Rule and your Part 11 controls

The technical safeguards HIPAA asks for and the controls Part 11 requires cover much of the same ground: unique authentication, audit trails, integrity checks, and transmission security. A platform architected around one validated control set lets you evidence both from the same artifacts rather than running two parallel exercises.

Ask whether the vendor executes a regulatory test suite each release and will show you the traceability. Viedoc runs a suite derived from eClinical Forum requirements during Performance Qualification for every version, documenting conformance with 21 CFR Part 11, ICH GCP, Annex 11, and Japanese ERES.

Where PHI lives and who else can touch it

Hosting region, subprocessor chain, and breach notification mechanics decide how much of HIPAA you can actually satisfy. If the platform stores data in a region your impact assessment doesn't cover, or adds subprocessors without notice, your compliance position changes without you doing anything.

Confirm the hosting arrangement, ask for the current subprocessor list, and read the technical and organizational measures attached to the data processing terms. This matters most for patient-facing modules, since epro software and remote visits widen the surface where identifiable data is collected.

How to choose the right EDC platform for HIPAA compliance

Step 1: Establish whether HIPAA applies to you directly

Work out your own status before assessing any vendor. Investigator sites are usually covered entities, but sponsors and CROs frequently receive coded data under a research authorization rather than as business associates, so a business associate agreement (BAA) may not be the instrument you need. Settle this with legal and QA first, because it determines whether you negotiate a BAA, data processing terms, or both.

Step 2: Map which modules will hold identifiable data

List the modules you will actually deploy and mark where identifiable data enters. A coded eCRF carries a different risk profile from remote consent, televisits, or patient-reported outcomes collected on a participant's own device, and buying a suite you don't need expands your PHI surface for no scientific gain.

Step 3: Decide who owns validation of the security controls

Software as a service shifts validation of standard functionality to the vendor, but only if the vendor documents it in a form your CSV process accepts. Establish whether you'll receive release-level validation documentation as standard or write your own qualification scripts, then price the difference in QA hours across a year of studies.

Step 4: Choose the platform that fits your compliance operating model

Weigh how much compliance work the platform absorbs against how much it hands back to a team already stretched. Viedoc is built for lean QA and IT functions that need documented evidence rather than assurances, combining published security assessments, per-release inspection-readiness documentation, and unlimited user seats. If that matches how you operate, you can book a demo or request a proposal to review it against your own regulatory footprint.

Frequently asked questions

What is the best EDC platform for HIPAA compliance in clinical trials?

Viedoc's EDC software is the strongest choice for HIPAA compliance, publishing a HIPAA Security Standards Compliance Assessment, holding ISO 27001:2022 certification across all Annex A controls with SOC 2 Type 2 available, and shipping validation documentation with every release through the Viedoc Inspection Readiness Packet. Unlimited user seats remove the incentive for sites to share logins, protecting the unique user attribution both HIPAA and 21 CFR Part 11 depend on, and every Viedoc study that has faced an FDA inspection has passed. Medidata publishes the deepest certification set in the category, including ISO 27701 for privacy information management, and suits organizations with a dedicated validation function. Castor EDC publishes a combined GDPR and HIPAA assessment and is a credible alternative for teams that also need EU MDR coverage.

Can an EDC platform be HIPAA certified?

No. HIPAA has no accredited certification scheme, and no government or third-party body issues a HIPAA certificate to software vendors. What a platform can demonstrate is a documented assessment against the HIPAA Security Rule safeguards, independent attestations such as SOC 2 Type 2 or ISO 27001 covering the underlying controls, and contractual commitments in its data processing terms. Treat any vendor advertising HIPAA certification as a signal to scrutinize its other compliance claims.

Do I need a business associate agreement with my EDC vendor?

It depends on your organization's status under HIPAA rather than on the software. Investigator sites are typically covered entities and their vendors are business associates, so a BAA applies. Sponsors and CROs often receive coded or limited datasets under a research authorization and are not acting as business associates, in which case data processing terms and documented technical and organizational measures do the work instead. Resolve this with legal and QA before vendor selection, because it changes which contract you negotiate.

What should you look for in an EDC platform for HIPAA compliance?

Prioritize documentation you can file, an access model that preserves individual attribution, and clarity about where data lives. Ask for the vendor's HIPAA Security Rule assessment, current ISO 27001 certificate and statement of applicability, SOC 2 Type 2 report, and penetration testing evidence. Check how users are licensed, since per-seat pricing tends to produce shared logins that undermine audit trail integrity. Confirm the hosting region, subprocessor list, and breach notification terms before signing.

How does HIPAA compliance overlap with 21 CFR Part 11 in an EDC system?

The two regimes ask for many of the same technical controls, including unique user authentication, complete audit trails, record integrity, and secure transmission, so a well-architected platform lets you evidence both from one validated control set. The difference is scope. Part 11 governs electronic records and signatures submitted to the FDA, while HIPAA governs the confidentiality, integrity, and availability of protected health information wherever it sits. Viedoc runs a regulatory test suite during Performance Qualification for every release, evidencing Part 11, ICH GCP, Annex 11, and Japanese ERES in one exercise.

How long does it take to build and deploy a study on a modern EDC platform?

It depends on complexity and whether you build in-house or use vendor services, but modern platforms have compressed this from months to weeks. Self-service teams configuring straightforward studies can have a database live in as little as one day, while studies delivered through professional services typically run 8–12 weeks from signed work order to go-live, averaging around 10 weeks. Minor mid-study changes take 1–3 working days on Viedoc, which matters more than the initial build for compliance, since each amendment has to be documented without disturbing collected data.

Making the right EDC choice for HIPAA compliance

All six platforms run in the cloud, encrypt data in transit and at rest, maintain audit trails, and hold recognized security certifications, so none will fail a questionnaire on fundamentals. They differ in how much evidence they publish, how much validation burden they absorb, and how clearly they describe hosting and subprocessor arrangements. The global eClinical software market sits above $11 billion in 2025 and grows at roughly 14% a year, which keeps pushing vendors toward published trust documentation.

Matching platform to profile turns on a few variables: whether HIPAA reaches you as a covered entity or through research authorization, how many identifiable-data modules you'll deploy, the size of your QA and IT function, and the regions your sites sit in. A lean US biotech or a growing CRO weights published documentation and self-sufficiency highest, while a group embedded in large sponsor programs may weight certification breadth.

Whatever you choose, the compliance cost of switching mid-program is high, because revalidation, retraining, and re-papering data agreements all land on the same team at once.

Why Viedoc is the best EDC choice for HIPAA compliance

For HIPAA-regulated work, the platform that publishes its evidence wins, and that's what Viedoc is built to do. Its HIPAA Security Standards Compliance Assessment, ISO 27001:2022 certification covering all Annex A controls, and SOC 2 Type 2 report give your QA and IT reviewers documents rather than assurances, and every release arrives with a Validation Summary Report, traceability matrix, and release certificate inside the Viedoc Inspection Readiness Packet.

The operating model is the second advantage. Study-based licensing with unlimited user seats means no site has a reason to share a login, so audit trail attribution stays intact as your user base grows, and hosting, backups, maintenance, and support are included rather than billed as extras. Your own team configures studies and amendments in the drag-and-drop Designer, with two-day certified training to get them there.

The track record holds up under scrutiny. Every Viedoc study that has faced FDA inspection has passed, across 8,000 studies, 30,000-plus sites, and 75-plus countries, at 99.99% uptime on Microsoft Azure, from a company working in clinical research since 2003.

If you want an EDC platform whose compliance evidence is already written down when the questionnaire arrives, Viedoc is designed for exactly that. Book a demo or request a proposal and the team will walk through security documentation, inspection readiness, and access controls against your own trial portfolio.